CBPE Capital LLP (“CBPE”) has invested in Veincentre alongside the CEO, Maurice McLoughlin. Veincentre is the UK’s largest dedicated provider of venous insufficiency treatments, primarily for varicose veins. The business provides services from 22 clinics across the UK and performs c.4,000 treatments per year through its specialist team of over 40 consultant vascular surgeons and interventional radiologists.
CBPE is investing in Veincentre to support the current management team’s growth plan which centres on enabling increased patient access to these treatments, while ensuring a continuation of the group’s exceptionally high standards of clinical care.
The investment in Veincentre continues CBPE’s successful track record of investing in and developing market-leading, high-growth healthcare businesses. The current portfolio includes Simbec-Orion, an oncology-focused full service phase I-III CRO, and Blatchford, one of the world’s leading providers of prosthetic and orthotic devices. Successful recent exits for CBPE in the healthcare sector include: Rodericks, the UK dental services provider; Optima, the UK’s leading provider of corporate health and wellbeing services; Medica, the UK market leader in teleradiology; and SpaMedica, the UK’s largest cataract surgery specialist.
Patients come to us because they know we are the dedicated experts in treating venous reflux disorder. In CBPE we have found an investor with an equal passion for the business and a strong track record in growing multi-site healthcare businesses. We are excited for what the future holds for Veincentre.
Venous insufficiency is an extremely common condition, with varicose veins or venous ulcers affecting over 7m people in the UK. Patients are often not aware that these problems can be treated with a short outpatient procedure under local anaesthetic, with patients leaving the clinic shortly thereafter. Patients often suffer for years with these conditions, and we are excited about backing Maurice and his team to ensure these services are made as accessible as possible to people all over the UK.
CBPE’s investment in Veincentre was led by Anand Jain and Rupert Parker with support from Gessica Howarth. Anand Jain and Rupert Parker will join the Board of Veincentre. CBPE was advised by Eversheds Sutherland (legal), FRP Advisory (debt advisory), PwC (tax and structuring), Candesic (commercial) and AJ Gallagher (insurance).
Terms of the transaction have not been disclosed.
